Menu
Washingtoner
  • Home
  • Technology
  • Boeing
  • Daryl Guberman
  • Aerospace
  • Health
  • Business
  • ANSI-ANAB
  • Services
Washingtoner

Juventix Regenerative Medical PRP Highlighted in University-Published Research Study
Washingtoner/10277008

Trending...
  • Tacoma: Lincoln Avenue Bridge to Close Saturday, April 18 for Asphalt Repairs
  • Su Che Publishing Announces New Children's Book Celebrating Vaisakhi Festival
  • Permian Museum Adds Photos of Fossils Discovered on a Meteorite
Laboratory Testing for Product Validation BSR Labs Juventix PRP Study Table Juventix Packaging With Tubes Juventix Regenerative Medical, LLC
TAMPA, Fla. - Washingtoner -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.

The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.

Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
  • 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
  • 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
  • Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
  • Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
  • Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
"The inclusion of Juventix PRP in a peer-reviewed study underscores our commitment to delivering scientifically validated, high-quality regenerative solutions," said Lance Liberti, CEO of Juventix Regenerative Medical. "Our focus on innovation ensures practitioners can trust Juventix PRP for consistent, superior patient outcomes."

More on Washingtoner
  • Engineering leaders from industry, academia to gather at IISE Annual Conference & Expo in Arlington, Texas
  • AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • BestDoc Launches AI Call Center for Healthcare
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • Grange Insurance Association to Rebrand as Granwest Insurance on July 1, 2026

Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/

About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.

For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777

More on Washingtoner
  • Dr. Rosendo Icochea, MD Recognized for Contributions to Surgical Education and Medical Research
  • Giftella Launches AI Gift-Finder App That Replaces Guesswork With Personalized Picks in Seconds
  • Beverly.io Announces Nationwide Expansion and Poppins Payroll Partnership for Families
  • City Council Adopts Resolution Transmitting 'Connect Tacoma' Ballot Measure to Pierce County Auditor for August 4, 2026 Primary Election Ballot
  • Lucky Envelope Brewing Celebrates 11th Anniversary

✉️ Email:
hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.

Media Contact
Lance Liberti
***@juventix.com
866-693-4777


Source: Juventix Regenerative Medical, LLC

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
  • All American Home Renovators: Transforming Bathrooms into Masterpieces, One Home at a Time
  • Bold Beauty Project Celebrates Anniversary with Collaborative Exhibition at FIU's Miami Beach Urban Studios
  • Pacific Emblem Company Launches "Happy 250th Birthday America" Collection and Proud Supporter of the Gary Sinise Foundation
  • Vangal Invests $8.5M in Peridot, Expanding into Enterprise AI Governance and Shadow AI Control
  • Bold Beauty Project Announces Exhibition at Palazzo Mora Venice, Italy
  • Financial Educator Jessica Perrone Launches Free "3 Stages of Building Wealth" Course for Women
  • Captain Notepad Expands Free Custom Design Services Across Full Product Line
  • Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes
  • YOKE Expands NIL Club Into Athlete-Led Commerce With Athlete Merch Launch
  • Floor Kings Announces Official Launch of Premier Epoxy Flooring Services Across Arizona
  • UK Buyers Purchase Luxury Home in Keene's Pointe, Windermere (Orlando, Florida)
  • Instant IP Launches Rapid Takedown Service to Combat IP Theft, Deepfakes, and Copycat Websites
  • Tacoma: Lincoln Avenue Bridge to Close Saturday, April 18 for Asphalt Repairs
  • City of Tacoma Invites Community to Shape the Future of Their Neighborhoods at Upcoming Code Update Event
  • Su Che Publishing Announces New Children's Book Celebrating Vaisakhi Festival
  • Permian Museum Adds Photos of Fossils Discovered on a Meteorite
  • This Saturday: Open House for Manalapan's Newest Single Family Home Community
  • Radarsign™ Awarded Sourcewell Contract Expanding Access to Traffic Safety Solutions
  • MainConcept and NETINT Bring VPU Acceleration to Easy Video API
_catLbl0 _catLbl1

Popular on Washingtoner

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 543
  • A Letter From the Tacoma City Council to the Sound Transit Board
  • Foiling Freaks Launches New Online Platform Dedicated to Foiling Board Sports
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
  • Spokane: US 195 Project To Improve Traffic Safety
  • JEGS Launches Modern, Secure Payments Powered by PhaseZero.ai
  • Spokane: 2025 Longitudinal Systems Analysis Shows Decreased Need for Homeless Services, Increase in Successful Exits to Stability
  • Tacoma: Lincoln Avenue Bridge to Close Saturday, April 18 for Asphalt Repairs
  • Heritage at Manalapan Introduces New Single-Family Home Community in One of Monmouth County's Most Desirable Locations
  • Mensa Brings National Board Game Competition to Northern Virginia April 16-19

Similar on Washingtoner

  • Contracting Resources Group and Aalis Management Consulting Launch ARG Joint Venture Under SBA Mentor-Protégé Program
  • EduCare Inc. Bridges Critical Gap in Breast Cancer Education with Spanish COPE Library Launch
  • Engineering leaders from industry, academia to gather at IISE Annual Conference & Expo in Arlington, Texas
  • AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • BestDoc Launches AI Call Center for Healthcare
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • Dr. Rosendo Icochea, MD Recognized for Contributions to Surgical Education and Medical Research
  • CCHR Rejects Global Psychiatric Push to Electroshock Children
  • Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
  • Bold Beauty Project Celebrates Anniversary with Collaborative Exhibition at FIU's Miami Beach Urban Studios
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute